Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2021 · 1 min read
In brief
In brief
This study quantifies the T2-FLAIR mismatch sign using geographically weighted regression to predict IDH-mutant 1p/19q noncodeleted gliomas from preoperative MRI. The method achieved 0.98 AUC in classifying molecular subtypes, offering an objective computational approach to supplement visual radiologic assessment of lower-grade gliomas.
Written by the GCMD Library team from the article.
Statements in this article
The T2-FLAIR mismatch sign is a validated imaging sign of isocitrate dehydrogenase-mutant 1p/19q noncodeleted gliomas.
The T2-FLAIR mismatch sign identifies isocitrate dehydrogenase-mutant 1p/19q noncodeleted gliomas with a high positive predictive value.
Geographically weighted regression can be used to estimate the T2-FLAIR mismatch sign objectively from multiparametric MR imaging scans.
Statistically significant differences (P value = .05) exist between the averages of residual signatures for isocitrate dehydrogenase-mutant 1p/19q noncodeleted tumors versus other categories.
The classifier predicts isocitrate dehydrogenase-mutant 1p/19q noncodeleted cases with area under the curve of 0.98 and high specificity and sensitivity.